Dentsply Sirona Inc. (XRAY)
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
DENTSPLY SIRONA Q2 Earnings Call Highlights
DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its turnaround plan amid lower volumes in several businesses and distributor inventory reductions in Europe.
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales
DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained.
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.52 per share a year ago.
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
XRAY leans on its Return-to-Growth plan, new distributor wins and AI-enabled launches ??? while forex and Europe demand softness linger.
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?
XRAY Stock Down as Q1 Earnings Miss Estimates, Margins Contract
DENTSPLY SIRONA stock slips after Q1 earnings miss estimates as margin pressure offsets revenue growth in key healthcare segments.
DENTSPLY SIRONA Inc. (XRAY) Q1 2026 Earnings Call Transcript
DENTSPLY SIRONA Inc. (XRAY) Q1 2026 Earnings Call Transcript
